Can Fite Biofarma Stock (AMEX: CANF) stock price, news, charts, stock research, profile.
Open | $2.24 |
Close | $2.37 |
Volume / Avg. | 48.26K / 108.95K |
Day Range | $2.24 - $2.47 |
52 Wk Range | 1.81 - 4.69 |
Market Cap | $11.83M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | AMEX |
RSI | 40 |
Short Interest | - |
Days to Cover | 1.16 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Can Fite Biofarma (AMEX:CANF) through any online brokerage.
Other companies in Can Fite Biofarma’s space includes: Eterna Therapeutics (NASDAQ:ERNA), Monopar Therapeutics (NASDAQ:MNPR), BioRestorative Therapies (NASDAQ:BRTX), GlycoMimetics (NASDAQ:GLYC) and ABVC BioPharma (NASDAQ:ABVC).
Can Fite Biofarma has a consensus price target of $14.00.
The stock price for Can Fite Biofarma (AMEX: CANF) is $2.37 last updated August 23, 2024 at 8:00 PM EDT.
There are no upcoming dividends for Can Fite Biofarma.
Can Fite Biofarma’s Q2 earnings are confirmed for Friday, November 15, 2024.
There is no upcoming split for Can Fite Biofarma.
Can Fite Biofarma is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.